EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $105 | -21.1% | 18,279 | +5.8% | 0.00% | – |
Q2 2023 | $133 | -29.3% | 17,276 | -38.3% | 0.00% | – |
Q1 2023 | $188 | +15.3% | 28,016 | +53.7% | 0.00% | – |
Q4 2022 | $163 | -99.8% | 18,233 | +95.7% | 0.00% | – |
Q3 2022 | $91,000 | -94.8% | 9,315 | -95.8% | 0.00% | -100.0% |
Q2 2022 | $1,746,000 | -18.2% | 219,308 | -0.3% | 0.00% | -50.0% |
Q1 2022 | $2,134,000 | – | 219,960 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,553,661 | $50,494,000 | 11.75% |
Novo Holdings A/S | 5,587,207 | $181,584,000 | 7.50% |
Orbimed Advisors | 13,944,680 | $453,202,000 | 4.24% |
Logos Global Management LP | 1,056,812 | $34,346,000 | 3.35% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $127,827,000 | 2.69% |
EcoR1 Capital, LLC | 1,224,175 | $39,786,000 | 1.76% |
Cormorant Asset Management, LP | 2,340,914 | $74,307,000 | 1.66% |
Octagon Capital Advisors LP | 125,000 | $4,063,000 | 1.53% |
RA Capital Management | 2,613,623 | $84,943,000 | 1.28% |
Soleus Capital Management, L.P. | 100,000 | $3,250,000 | 0.59% |